Wedbush reaffirmed their outperform rating on shares of Stericycle (NASDAQ: SRCL) in a research note released on Monday morning. They currently have a $110.00 price target on the stock, up from their previous price target of $102.00.

“With strength in its core business and new service offerings gaining traction, the company is positioned to grow non-GAAP EPS in the midteens over the next several years supported by: (i) uptake in new services within small quantity (SQ) generators, including retail service offering (StrongPak) and Patient Communication Services (PCS); (ii) scaling of pharmaceutical waste services (Rx Waste) with large quantity (LQ) generators improves customer margin profile; and (iii) free cash flow to fund strategic M&A opportunities.,” Wedbush’s analyst commented.

Several other analysts have also recently commented on the stock. Analysts at Goldman Sachs initiated coverage on shares of Stericycle in a research note to investors on Wednesday, March 13th. They set a buy rating and a $115.00 price target on the stock. Separately, analysts at Zacks reiterated a neutral rating on shares of Stericycle in a research note to investors on Wednesday, February 27th. They now have a $100.00 price target on the stock. Finally, analysts at Barclays Capital raised their price target on shares of Stericycle from $102.00 to $103.00 in a research note to investors on Friday, February 8th. They now have an equal weight rating on the stock.

Three research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. The company has an average rating of Buy and an average target price of $104.35.

Shares of Stericycle (NASDAQ: SRCL) opened at 101.54 on Monday. Stericycle has a 52 week low of $81.16 and a 52 week high of $102.21. The stock’s 50-day moving average is currently $97.04. The company has a market cap of $8.741 billion and a P/E ratio of 32.97.

Stericycle, Inc. is engaged in the business of managing regulated waste and providing an array of related services.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.